Bigelow Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Buy |
3,084
+200
| +7% | +$13.8K | 0.09% | 145 |
|
|
2025
Q1 | $200K | Buy |
+2,884
| New | +$200K | 0.1% | 146 |
|
|
2024
Q4 | – | Sell |
-2,123
| Closed | -$253K | – | 153 |
|
|
2024
Q3 | $253K | Buy |
2,123
+118
| +6% | +$14.1K | 0.11% | 146 |
|
|
2024
Q2 | $286K | Hold |
2,005
| – | – | 0.14% | 134 |
|
|
2024
Q1 | $257K | Buy |
+2,005
| New | +$257K | 0.13% | 142 |
|
|
2023
Q1 | – | Sell |
-3,000
| Closed | -$203K | – | 150 |
|
|
2022
Q4 | $203K | Buy |
+3,000
| New | +$203K | 0.12% | 142 |
|